Analysts’ Viewpoint
Telehealth and eHealth mobile apps hold potentials to increase awareness about the benefits of hyperbaric oxygen therapy devices post the COVID-19 outbreak. However, these devices are linked with disadvantages such as complications with regard to oxygen toxicity, discomfort during therapy, and high investment cost for innovating in technology. Hence, companies in the hyperbaric oxygen therapy devices market should seek funding from healthcare organizations and recommend doctor’s consultation before opting for the treatment.
Surge in prevalence of diabetes, increase in research funding, technological advancements, and rise in government support are key drivers that are projected to steer growth of the global market during the forecast period.
The hyperbaric oxygen therapy (HBOT) is known to treat various health problems such as carbon monoxide poisoning and diabetic foot ulcers. World's most prominent and advanced subsea, offshore, and life support solution providers are collaborating with researchers to launch next-generation multiplace hyperbaric oxygen treatment chambers.
Leading providers of multiplace hyperbaric services for acute care hospitals and trauma centers are announcing the official launch of hyperbaric aware website and national campaigns. Stakeholders in the market for hyperbaric oxygen therapy devices are increasing awareness about the therapy’s advantages to effectively deal with various chronic conditions. Moreover, the U.S. Food and Drug Administration (FDA) granted permission for commercializing and promoting ClearMate. It is a new device intended to be utilized in the emergency room in order to treat patients suffering from carbon monoxide poisoning.
Due to a decline in clinical and hospital visits amid the ongoing COVID-19 outbreak, financial situations have been strained for stakeholders in the hyperbaric oxygen therapy devices industry. Nevertheless, reopening of healthcare facilities and increase in medical care services in hospitals & clinics due to subside in the pandemic cases are helping market stakeholders to stay resilient.
Participants in the hyperbaric oxygen therapy devices industry are taking help of government stimulus packages to stay financially afloat. They are focusing on key medical services for wound healing, infection treatment, and decompression sickness to generate cash flows and revive the global healthcare ecosystem.
There is a possibility that patients could face difficulties with the HBO therapy such as confinement anxiety, oxygen toxicity in lungs & central nervous system, barotraumatic lesions, and ocular effects including cataract growth and myopia. It has been found that a number of patients experience ear pain or discomfort as an expression of problems during the hyperbaric oxygen therapy.
Moreover, hyperbaric oxygen therapy is a niche segment and requires significant investment for drawing new innovations. This deters companies to enter the market, owing to uncertainty of receiving expected profit. Nevertheless, the market is projected for a robust CAGR throughout the assessment period, which is evident due to high incidence and prevalence of carbon monoxide poisoning, diabetic foot ulcers, Alzheimer’s, and wound healing requirements.
Recent studies suggest that oxygen has been found to be a crucial element for improvements in skin complexion and skin rejuvenations. The adoption of HBOT for this purpose is consistently increasing. Medical aesthetics clinics are using the oxygen therapy under high pressure applied directly to skin in order to decrease visible wrinkles. This therapy plays an instrumental role to provide rejuvenated & aesthetic benefits to the individual whilst removing toxins from skin.
Healthcare providers in the hyperbaric oxygen therapy devices industry are investing in setting-up dedicated hyperbaric oxygen facilities with regenerative medicine. Such facilities are focused on improving clinical numbers for age-related diseases and infections.
Monoplace HBOT devices are generating incremental opportunities for companies in the global market, owing to their technological advancements and cost-effectiveness. The adoption of monoplace HBOT devices in hospitals and clinics has increased primarily as patients can expect more privacy & comfort with quicker treatments.
Ease of installation & handling and low maintenance of monoplace HBOT devices are estimated to boost the market during the forecast period. Moreover, rise in penetration of these devices to provide user-friendly operability and portability is anticipated to propel its demand in the upcoming decade.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 3.1 Bn |
|
Market Forecast Value in 2031 |
US$ 7.3 Bn |
|
Growth Rate (CAGR) |
8.9% |
|
Forecast Period |
2021–2028 |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It is expected to reach the value of US$ 7.3 Bn by the end of 2028
It is estimated to expand at a CAGR of 8.9% from 2021 to 2028
Hyperbaric oxygen therapy devices market is driven by rise in penetration of these devices to provide user-friendly operability and portability
North America accounted for a major share of the global market during the forecast period
Key players in the global market include Perry Baromedical, Environmental Tectonics Corporation, Fink Engineering Pty Ltd., Sechrist Industries, Inc., HAUX-LIFE-SUPPORT
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hyperbaric Oxygen Therapy Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Regulatory Scenario, by Region/globally
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. COVID-19 Pandemics Impact on Industry
6. Global Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Monoplace HBOT Devices
6.3.2. Multiplace HBOT Devices
6.4. Market Attractiveness Analysis, by Product
7. Global hyperbaric Oxygen Therapy Devices market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Wound Healing
7.3.2. Decompression Sickness
7.3.3. Infection Treatment
7.3.4. Gas Embolism
7.4. Market Attractiveness Analysis, by Application
8. Global hyperbaric Oxygen Therapy Devices market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Monoplace HBOT Devices
9.2.2. Multiplace HBOT Devices
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Wound Healing
9.3.2. Decompression Sickness
9.3.3. Infection Treatment
9.3.4. Gas Embolism
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Application
9.5.3. By Country
10. Europe Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Monoplace HBOT Devices
10.2.2. Multiplace HBOT Devices
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Wound Healing
10.3.2. Decompression Sickness
10.3.3. Infection Treatment
10.3.4. Gas Embolism
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Monoplace HBOT Devices
11.2.2. Multiplace HBOT Devices
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Wound Healing
11.3.2. Decompression Sickness
11.3.3. Infection Treatment
11.3.4. Gas Embolism
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Monoplace HBOT Devices
12.2.2. Multiplace HBOT Devices
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Wound Healing
12.3.2. Decompression Sickness
12.3.3. Infection Treatment
12.3.4. Gas Embolism
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Monoplace HBOT Devices
13.2.2. Multiplace HBOT Devices
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Wound Healing
13.3.2. Decompression Sickness
13.3.3. Infection Treatment
13.3.4. Gas Embolism
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Application
13.5.3. By Country
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Environmental Tectonics Corporation
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Analysis
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Perry Baromedical
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Analysis
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Sechrist Industries, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Analysis
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Fink Engineering Pty Ltd
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Analysis
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Gulf Coast Hyperbarics, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Analysis
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. HAUX-LIFE-SUPPORT
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Analysis
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Hearmec Co., Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Analysis
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. Hyperbaric SAC
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Analysis
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Royal IHC
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Analysis
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
14.3.10. OxyHeal International, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Analysis
14.3.10.3. Growth Strategies
14.3.10.4. SWOT Analysis
14.3.11. SOS Group Global Ltd.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Financial Analysis
14.3.11.3. Growth Strategies
14.3.11.4. SWOT Analysis
14.3.12. Medical Equipment and Consumer Goods Plant (KhSC)
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Financial Analysis
14.3.12.3. Growth Strategies
14.3.12.4. SWOT Analysis
14.3.13. Submarine Manufacturing And Products Limited (SMP Ltd)
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Financial Analysis
14.3.13.3. Growth Strategies
14.3.13.4. SWOT Analysis
14.3.14. OxyHealth
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Financial Analysis
14.3.14.3. Growth Strategies
14.3.14.4. SWOT Analysis
14.3.15. Pan-America Hyperbarics, Inc.
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Financial Analysis
14.3.15.3. Growth Strategies
14.3.15.4. SWOT Analysis
14.3.16. Tekna Manufacturing, LLC
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Financial Analysis
14.3.16.3. Growth Strategies
14.3.16.4. SWOT Analysis
14.3.17. Baroks Hyperbaric A.S
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Financial Analysis
14.3.17.3. Growth Strategies
14.3.17.4. SWOT Analysis
14.3.18. Sands Hyperbarics
14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.18.2. Financial Analysis
14.3.18.3. Growth Strategies
14.3.18.4. SWOT Analysis
14.3.19. PCCI, Inc.
14.3.19.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.19.2. Financial Analysis
14.3.19.3. Growth Strategies
14.3.19.4. SWOT Analysis
List of Tables
TABLE 1: Market Snapshot: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market
TABLE 2: Global Prevalence of Acute and Chronic Wounds, by Type
TABLE 3: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market Revenue (US$ Mn), by Product, 2017–2031
TABLE 4: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market Revenue (US$ Mn), by Application, 2017–2031
TABLE 5: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market Revenue (US$ Mn), by Region, 2017–2031
TABLE 6: North America Hyperbaric Oxygen Therapy (HBOT) Devices Market Revenue (US$ Mn), by Product, 2017–2031
TABLE 7: Europe Hyperbaric Oxygen Therapy (HBOT) Devices Market Revenue (US$ Mn), by Product, 2017–2031
TABLE 8: Asia Pacific Hyperbaric Oxygen Therapy (HBOT) Devices Market Revenue (US$ Mn), by Product, 2017–2031
TABLE 9: Latin America Hyperbaric Oxygen Therapy (HBOT) Devices Market Revenue (US$ Mn), by Product, 2017–2031
TABLE 10: Middle East & Africa Hyperbaric Oxygen Therapy (HBOT) Devices Market Revenue (US$ Mn), by Product, 2017–2031
List of Figures
FIG. 1: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market Segmentation
FIG. 2: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, by Product, 2021
FIG. 3: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, by Application, 2021
FIG. 4: Comparative Analysis: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, by Geography, 2021 and 2031 (Value %)
FIG. 5: Hyperbaric Oxygen Therapy (HBOT) Devices Market, Drivers and Restraints
FIG. 6: Porter’s Five Forces Analysis: Hyperbaric Oxygen Therapy (HBOT) Devices Market
FIG. 7: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market: Value Chain Analysis
FIG. 8: Market Attractiveness Analysis: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, by Geography
FIG. 9: Market Share Analysis: Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, by Key Players, 2021 (Value %)
FIG. 10: Global Monoplace HBOT Devices Market Revenue (US$ Mn), 2017–2031
FIG. 11: Global Multiplace HBOT Devices Market Revenue (US$ Mn), 2017–2031
FIG. 12: Global Topical HBOT Devices Market Revenue (US$ Mn), 2017–2031
FIG. 13: Global HBOT Wound Healing Market Revenue (US$ Mn), 2017–2031
FIG. 14: Global HBOT Decompression Sickness Market Revenue (US$ Mn), 2017–2031
FIG. 15: Global HBOT Air or Gas Embolism Market Revenue (US$ Mn), 2017–2031
FIG. 16: Global HBOT Infection Treatment Market Revenue (US$ Mn), 2017–2031
FIG. 17: Global Other HBOT Application Market Revenue (US$ Mn), 2017–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Hyperbaric Oxygen Therapy Devices Market
